Real-world discontinuation of hepatitis C drugs was low, but it was 3 times more likely than in clinical trials and varied by patient characteristics.
Thomas Riley III, MD
Advertisement
Articles by Thomas Riley III, MD
Advertisement
Latest Updated Articles
- Discontinuation of New Hepatitis C Drugs Among Medicare Patients
Published: February 12th 2020 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Trump Administration Flags Potential Link Between Prenatal Acetaminophen Use, Autism
2
Childhood Cancer Awareness Month Spotlights Barriers That Persist in Care
3
Nicotinamide Reduces New Skin Cancer Risk in Large Veteran Study
4
More Effective CKD Strategy Could Have Health, Societal Benefits
5
